Search Results - "Delabesse, Eric"
-
1
Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial
Published in Journal of clinical oncology (20-08-2018)“…Purpose To evaluate randomly the role of hyperfractionated cyclophosphamide (hyper-C) dose intensification in adults with newly diagnosed Philadelphia…”
Get full text
Journal Article -
2
Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells
Published in Blood (18-02-2016)“…Internal tandem duplication of the Fms-like tyrosine kinase-3 receptor (FLT3) internal tandem duplication (ITD) is found in 30% of acute myeloid leukemia (AML)…”
Get full text
Journal Article -
3
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
Published in Journal of clinical oncology (20-02-2009)“…Retrospective comparisons have suggested that adolescents or teenagers with acute lymphoblastic leukemia (ALL) benefit from pediatric rather than adult…”
Get full text
Journal Article -
4
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers
Published in Blood (06-08-2020)“…Acute erythroleukemia (AEL or acute myeloid leukemia [AML]-M6) is a rare but aggressive hematologic malignancy. Previous studies showed that AEL leukemic cells…”
Get full text
Journal Article -
5
Dexamethasone in hyperleukocytic acute myeloid leukemia
Published in Haematologica (Roma) (01-06-2018)“…Patients with acute myeloid leukemia and a high white blood cell count are at increased risk of early death and relapse. Because mediators of inflammation…”
Get full text
Journal Article -
6
Somatic genetic alterations predict hematological progression in GATA2 deficiency
Published in Haematologica (Roma) (01-06-2023)“…Germline GATA2 mutations predispose to myeloid malignancies resulting from the progressive acquisition of additional somatic mutations. Here we describe…”
Get full text
Journal Article -
7
CHK1 as a therapeutic target to bypass chemoresistance in AML
Published in Science signaling (13-09-2016)“…The nucleoside analog cytarabine, an inhibitor of DNA replication fork progression that results in DNA damage, is currently used in the treatment of acute…”
Get more information
Journal Article -
8
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL
Published in Haematologica (Roma) (10-03-2022)“…Blinatumomab is a bispecific T-cell engager approved for B-cell precursor acute lymphoblastic leukemia (B-ALL) with persistent minimal residual disease (MRD)…”
Get full text
Journal Article -
9
Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients
Published in Haematologica (Roma) (01-10-2017)“…Long non-coding RNAs are defined as transcripts larger than 200 nucleotides but without protein-coding potential. There is growing evidence of the important…”
Get full text
Journal Article -
10
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
Published in Blood (08-10-2009)“…Oncogenic pathways underlying in the development of myelodysplastic syndromes (MDS) remain poorly characterized, but mutations of the ten-eleven translocation…”
Get full text
Journal Article -
11
Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors
Published in The EMBO journal (17-06-2002)“…Stem cells are a central feature of metazoan biology. Haematopoietic stem cells (HSCs) represent the best‐characterized example of this phenomenon, but the…”
Get full text
Journal Article -
12
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine
Published in PloS one (01-10-2020)“…Hypomethylating agents are a classical frontline low-intensity therapy for older patients with acute myeloid leukemia. Recently, TP53 gene mutations have been…”
Get full text
Journal Article -
13
PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice
Published in Proceedings of the National Academy of Sciences - PNAS (09-10-2018)“…PAX5 is a well-known haploinsufficient tumor suppressor gene in human B-cell precursor acute lymphoblastic leukemia (B-ALL) and is involved in various…”
Get full text
Journal Article -
14
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study
Published in Blood cancer journal (New York) (31-05-2024)“…Acute myeloid leukemia (AML) with t(9;22) (q34.1; q11.2)/ BCR::ABL1 , a distinct entity within the group of AML with defining genetic abnormalities, belong to…”
Get full text
Journal Article -
15
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia
Published in Blood cancer journal (New York) (16-08-2022)“…Classifications of acute myeloid leukemia (AML) patients rely on morphologic, cytogenetic, and molecular features. Here we have established a novel flow…”
Get full text
Journal Article -
16
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia
Published in PloS one (06-02-2012)“…Chronic myelomonocytic leukemia (CMML) has recently been associated with a high incidence of diverse mutations in genes such as TET2 or EZH2 that are…”
Get full text
Journal Article -
17
Impact of obesity in favorable‐risk AML patients receiving intensive chemotherapy
Published in American journal of hematology (01-02-2016)“…We assessed the influence of obesity on the characteristics and prognosis of acute myeloid leukemia (AML). Indeed, safety of intensive chemotherapy and outcome…”
Get full text
Journal Article -
18
Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia
Published in Haematologica (Roma) (01-10-2014)Get full text
Journal Article -
19
LOSS OF HSC STEMNESS IDENTITY IS ASSOCIATED WITH EXHAUSTION AND HYPORESPONSIVENESS IN GATA2 DEFICIENCY SYNDROME
Published in EJC paediatric oncology (01-12-2023)Get full text
Journal Article -
20
Genomic landscape of hyperleukocytic acute myeloid leukemia
Published in Blood cancer journal (New York) (05-01-2022)“…Approximately 20% of patients with acute myeloid leukemia (AML) present at diagnosis with hyperleukocytosis, which is commonly defined as a white blood cell…”
Get full text
Journal Article